An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Inhibitors of the protease of HIV-1 have been used successfully for the treatment of HIV-1-infected patients and AIDS disease. We tested whether these protease inhibitory drugs exerted effects in addition to their antiviral activity. Here, we show in mice infected with lymphocytic choriomeningitis v...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	André, P, Groettrup, M, Klenerman, P, de Giuli, R, Booth, B, Cerundolo, V, Bonneville, M, Jotereau, F, Zinkernagel, R, Lotteau, V
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1998

Παρόμοια τεκμήρια

Role of the proteasome and non proteasomal proteases in the generation of CTL epitopes.
ανά: Cerundolo, V, κ.ά.
Έκδοση: (1998)

Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopes.
ανά: Kelleher, A, κ.ά.
Έκδοση: (2001)

Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic protein.
ανά: Gileadi, U, κ.ά.
Έκδοση: (1999)

Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes.
ανά: Klenerman, P, κ.ά.
Έκδοση: (1998)

The HIV Protease Inhibitor Nelfinavir Downregulates Akt Phosphorylation by Inhibiting Proteasomal Activity and Inducing the Unfolded Protein Response
ανά: Anjali K. Gupta, κ.ά.
Έκδοση: (2007-04-01)

CD8+ T cell epitope-flanking mutations disrupt proteasomal processing of HIV-1 Nef.
ανά: Milicic, A, κ.ά.
Έκδοση: (2005)

Competitive Metabolite Profiling of Natural Products Reveals Subunit Specific Inhibitors of the 20S Proteasome
ανά: Atul Pawar, κ.ά.
Έκδοση: (2020-01-01)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
ανά: Valmori, D, κ.ά.
Έκδοση: (1999)

Computational investigations of HIV-1 protease and protease inhibitors interactions
ανά: Sham, Hoi Fung
Έκδοση: (2014)

The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells.
ανά: Cerundolo, V, κ.ά.
Έκδοση: (1997)

Current and Novel Inhibitors of HIV Protease
ανά: Jan Konvalinka, κ.ά.
Έκδοση: (2009-12-01)

Conjugation of the ubiquitin activating enzyme UBE1 with the ubiquitin-like modifier FAT10 targets it for proteasomal degradation.
ανά: Johanna Bialas, κ.ά.
Έκδοση: (2015-01-01)

Alteration of HIV epitope processing and presentation by HIV protease inhibitors
ανά: Kourjian G, κ.ά.
Έκδοση: (2012-09-01)

Additivity in the Analysis and Design of HIV Protease Inhibitors
ανά: Jorissen, Robert N., κ.ά.
Έκδοση: (2012)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
ανά: V.B. Denisenko, κ.ά.
Έκδοση: (2010-02-01)

PRACTICE OF USING VIRAL PROTEASE INHIBITORS IN CHILDREN WITH HIV INFECTION
ανά: V.B. Denisenko, κ.ά.
Έκδοση: (2010-02-01)

Proteasome inhibitors as anti-cancer agents.
ανά: Murray, R, κ.ά.
Έκδοση: (2000)

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
ανά: Valmori, D, κ.ά.
Έκδοση: (1999)

Down-regulation of Akt signaling with HIV-1 protease inhibitors
ανά: Gupta, A, κ.ά.
Έκδοση: (2005)

Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
ανά: Larissa da Costa Souza, κ.ά.
Έκδοση: (2014-01-01)

New proteasome inhibitors in the management of multiple myeloma
ανά: S. V. Semochkin
Έκδοση: (2019-07-01)

MAPPING OF PATENTS RELATED TO PROTEASE INHIBITORS AND HIV
ανά: Romério Rodrigues dos Santos Silva, κ.ά.
Έκδοση: (2022-04-01)

Role of Gag in HIV Resistance to Protease Inhibitors
ανά: Fabrizio Mammano, κ.ά.
Έκδοση: (2010-07-01)

Two Novel Precursors of the HIV-1 Protease Inhibitor Darunavir Target the UPR/Proteasome System in Human Hepatocellular Carcinoma Cell Line HepG2
ανά: Roberta Rinaldi, κ.ά.
Έκδοση: (2021-11-01)

TRIM5α Restricts Flavivirus Replication by Targeting the Viral Protease for Proteasomal Degradation
ανά: Abhilash I. Chiramel, κ.ά.
Έκδοση: (2019-06-01)

Site-Specific Proteasome Inhibitors
ανά: Alexei F. Kisselev
Έκδοση: (2021-12-01)

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
ανά: Noah M. Merin, κ.ά.
Έκδοση: (2014-12-01)

Treatment with the HIV protease inhibitor nelfinavir triggers the unfolded protein response and may overcome proteasome inhibitor resistance of multiple myeloma in combination with bortezomib: a phase I trial (SAKK 65/08)
ανά: Christoph Driessen, κ.ά.
Έκδοση: (2016-03-01)

Human T-cell leukemia virus type 1 Tax protein binds to assembled nuclear proteasomes and enhances their proteolytic activity.
ανά: Hemelaar, J, κ.ά.
Έκδοση: (2001)

The capture proteasome assay (CAPA) to evaluate subtype-specific proteasome inhibitors
ανά: Nathalie Vigneron, κ.ά.
Έκδοση: (2015-09-01)

Evaluation of COVID-19 protease and HIV inhibitors interactions
ανά: Tran Linh, κ.ά.
Έκδοση: (2022-03-01)

Safety of protease inhibitors in HIV-infected pregnant women
ανά: Chougrani I, κ.ά.
Έκδοση: (2013-09-01)

Cardio-metabolic effectsof HIV protease inhibitors (lopinavir/ritonavir).
ανά: Kathleen M S E Reyskens, κ.ά.
Έκδοση: (2013-01-01)

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat
ανά: Konvalinka Jan, κ.ά.
Έκδοση: (2011-08-01)

Evaluation of Platelet Activation by HIV Protease Inhibitors – The HIV-PLA II Study
ανά: Kann G, κ.ά.
Έκδοση: (2021-08-01)

Immune surveillance and AIDS progression.
ανά: Zinkernagel, R, κ.ά.
Έκδοση: (1997)

Correspondence - Immune surveillance and AIDS progression
ανά: Zinkernagel, R, κ.ά.
Έκδοση: (1997)

Of mice and men: cytotoxic T cells and AIDS pathogenesis.
ανά: Klenerman, P, κ.ά.
Έκδοση: (1999)

What can we learn about human immunodeficiency virus infection from a study of lymphocytic choriomeningitis virus?
ανά: Klenerman, P, κ.ά.
Έκδοση: (1997)

Resistance associated mutations to protease inhibitors on HIV-2 infected patients in Portugal
ανά: J. Lopes, κ.ά.
Έκδοση: (2021-04-01)